$RXST

$4.93 -$0.09 (1.79%) Close

$RXST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$RXST Management Team

Mr. J. Andy Corley

Independent Chairman of the Board

Age 69

Compensation $262.4K USD

Sex Male

Dr. Ron Kurtz

President

Chief Executive Officer

Director

Age 59

Compensation $6.982M USD

Sex Male

Dr. Ilya Goldshleger

Co-President

Chief Operating Officer

Age 50

Compensation $5.819M USD

Sex Male

Mr. Eric Weinberg

Co-President

Chief Business Development Officer

Age 64

Compensation $5.797M USD

Sex Male

Mr. Mark Wilterding

Chief Financial Officer

Age 48

Compensation -

Sex Male

Mr. Scott Gaines

Chief Customer Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. J. Andy Corley Independent Chairman of the Board	69	$262.4K USD	Male
Dr. Ron Kurtz President Chief Executive Officer Director	59	$6.982M USD	Male
Dr. Ilya Goldshleger Co-President Chief Operating Officer	50	$5.819M USD	Male
Mr. Eric Weinberg Co-President Chief Business Development Officer	64	$5.797M USD	Male
Mr. Mark Wilterding Chief Financial Officer	48	-	Male
Mr. Scott Gaines Chief Customer Officer	-	-	Male

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

8 of 10

stated in the proxy

Average tenure

6.7 years

from year joined

CEO also chairs the board

J. Andy Corley

Director	Age	On board	Independent	Committees	Other public boards	Pay
William J. Link, Ph.D.	Not stated	2016 10 years	Not independent	None stated	Tarsus Pharmaceuticals	Not stated
Robert Warner	Not stated	2021 5 years	Independent	Compensation Committee	Oculis	Not stated
Shweta Singh Maniar	Not stated	2021 5 years	Independent	None stated	Orthofix Medical Inc.	Not stated
Julie B. Andrews	Not stated	2021 5 years	Independent	None stated	None stated	Not stated
Robert J. Palmisano	Not stated	2021 5 years	Independent	None stated	AEON Biopharma, Saluda Medical	Not stated
Tamara R. Fountain, M.D.	Not stated	2022 4 years	Independent	None stated	Sight Sciences	Not stated
Ron Kurtz, M.D. CEO, Executive officer	Not stated	2016 10 years	Not independent	None stated	None stated	Paid as CEO
J. Andy Corley Board chair	Not stated	2015 11 years	Independent	Compensation Committee Governance Committee	None stated	Not stated
Juliet Tammenoms Bakker	Not stated	2015 11 years	Independent	Audit Committee	Ceribell, Inc.	Not stated
Raymond W. Cohen	Not stated	2025 1 year	Independent	Audit Committee Compensation Committee	Kestra Medical Technologies	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 28, 2026

Praxis Management, LLC

Trust affiliated with director William J. Link, Ph.D. is a significant investor; Dr. Link's son-in-law serves as chief executive officer

Amount not stated

2025

Rebate and commission payments made and products sold to Praxis Management, LLC and related Praxis entities

Open in proxy

Jack Kurtz

son of Ron Kurtz, our President, Chief Executive Officer and a director

$141,887

2025

Employment as a non-executive employee, with total compensation earned in 2025

With RxSight, Inc. Open in proxy

Comments

Company Executives

$RXST Management Team

Mr. J. Andy Corley

Dr. Ron Kurtz

Dr. Ilya Goldshleger

Mr. Eric Weinberg

Mr. Mark Wilterding

Mr. Scott Gaines

Board of Directors

Related-party transactions